Related references
Note: Only part of the references are listed.Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes
Rajiv Mangla et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Updates in the management of high-grade glioma
David Bradley et al.
JOURNAL OF NEUROLOGY (2014)
Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression
German Reyes-Botero et al.
NEURO-ONCOLOGY (2014)
Recurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survival
Christina Chen et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images
Kourosh M. Naeini et al.
NEURO-ONCOLOGY (2013)
Survival and Prognostic Factors of Anaplastic Gliomas
Miriam Nuno et al.
NEUROSURGERY (2013)
MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set
David A. Gutman et al.
RADIOLOGY (2013)
Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma
L. S. Hu et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors
Tejas Sankar et al.
JOURNAL OF NEUROSURGERY (2012)
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology)
Silvia Scoccianti et al.
NEURO-ONCOLOGY (2012)
Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours
J. W. Kim et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Influence of Histological Subtype on Survival after Combined Therapy of Surgery and Radiation in WHO Grade 3 Glioma
Katsuyuki Shirai et al.
JOURNAL OF RADIATION RESEARCH (2010)
Anaplastic Gliomas
Lisa M. DeAngelis
JOURNAL OF CLINICAL ONCOLOGY (2009)
Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic
David A. Schomas et al.
NEURO-ONCOLOGY (2009)
Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imaging
Daniel P. Barboriak et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2008)
Prognostic significance of surgery and radiation therapy in cases of anaplastic astrocytoma: retrospective analysis of 170 cases
Takuma Nomiya et al.
JOURNAL OF NEUROSURGERY (2007)
Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma
GE Keles et al.
JOURNAL OF NEUROSURGERY (2006)
Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features
Michael D. Jenkinson et al.
BRAIN (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: Visual evaluation of brain tumors
T Kubota et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2005)
Correlations between molecular profile and radiologic pattern in oligodendroglial tumors
F Laigle-Donadey et al.
NEUROLOGY (2004)
Imaging correlates of molecular signatures in oligodendrogliomas
JF Megyesi et al.
CLINICAL CANCER RESEARCH (2004)
Peak contrast enhancement in CT and MR angiography: When does it occur and why? Pharmacokinetic study in a porcine model
KT Bae
RADIOLOGY (2003)
Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma
A Jackson et al.
BRITISH JOURNAL OF RADIOLOGY (2003)
Prognostic Pathologic implication of clinical, radiologic, and features in patients with anaplastic gliomas
A Tortosa et al.
CANCER (2003)
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
M Lacroix et al.
JOURNAL OF NEUROSURGERY (2001)
Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis -: Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes
PK Sallinen et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2000)
Share Paper
